Showing 672 news articles about New & experimental HIV treatments

Filters Content type: Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

Neurological & cognitive problems

NeurogesX to pursue expanded U.S. label for Qutenza® (capsaicin) 8% patch in HIV-associated neuropathy

Editor's pick
PR Newswire
18 October 2010
Government, leadership & policy

Fighting AIDS: An Oral History

Editor's pick
Slate
7 October 2010
New & experimental HIV treatments

Animal study reveals possible method for boosting the immune system to protect infants against HIV

Editor's pick
EurekAlert!
3 October 2010
The search for an HIV prevention vaccine

Norwegian Bionor Pharma to discontinue HIV vaccine development

Editor's pick
ADP News
1 October 2010
New & experimental HIV treatments

A drug against AIDS could be effective against the herpesvirus

Editor's pick
Science Daily
23 September 2010
New & experimental HIV treatments

Cytheris initiates INSPIRE 3, a phase II clinical trial of recombinant human interleukin-7 (CYT107) in chronically infected HIV patients

Editor's pick
Cytheris
22 September 2010
Hepatitis C treatment

Taribavirin offers a safe, effective alternative for chronic hepatitis C

Editor's pick
Eurekalert Medicine & Health
22 September 2010
How HIV works

Scientists reveal HIV cell mystery

Editor's pick
The Age
21 September 2010
New & experimental HIV treatments

ICAAC: Novel HIV drug a 'trade-off'

Editor's pick
MedPage Today
17 September 2010
New & experimental HIV treatments

Poor adherence, high viral loads help explain rilpivirine treatment failures

Editor's pick
AIDSMeds.com
17 September 2010
Drug interactions & pharmacokinetics

Raltegravir Pharmacokinetics Disrupted by Antacids in Healthy Patients With HIV: Presented at ICAAC

Editor's pick
Doctor's Guide
16 September 2010
New & experimental HIV treatments

ICAAC: Study Closes Vicriviroc Story

Editor's pick
MedPage Today
16 September 2010
New & experimental HIV treatments

GSK new NNRTI selects no resistance mutations in 7 days of monotherapy

Editor's pick
NATAP
16 September 2010
New & experimental HIV treatments

K.U.Leuven enters license agreement with Pfizer to commercialize anti-HIV drugs

Editor's pick
News-Medical-Net
16 September 2010
New & experimental HIV treatments

New NRTI festinavir exhibits good anti-HIV activity and safety in phase 1b/2a study

Editor's pick
HIVandhepatitis.com
15 September 2010
New & experimental HIV treatments

Elvitegravir "Quad" single-tablet regimen shows continued HIV suppression at 48 weeks

Editor's pick
HIVandhepatitis.com
15 September 2010
New & experimental HIV treatments

Gilead Sciences submits European marketing application for once-daily single-tablet regimen of Truvada(R) and TMC278 for the treatment of HIV infection

Editor's pick
Market Watch
3 September 2010
New & experimental HIV treatments

AIDS cure quest to kill `sleeping' viruses enlists Merck cancer medicine

Editor's pick
Bloomberg
2 September 2010
New & experimental HIV treatments

Cocktails are next for cancer-drug makers

Editor's pick
Bloomberg Business Week
27 August 2010
New & experimental HIV treatments

Researchers Identify Two FDA Approved Drugs That May Fight HIV

Editor's pick
Science Daily
24 August 2010
New & experimental HIV treatments

Chimerix's CMX157 Shows Potential to Treat Multi-Drug-Resistant HIV and Improve the Activity and Toxicity Profile of Tenofovir

Editor's pick
PR Newswire
28 July 2010
New & experimental HIV treatments

Therapeutic HIV vaccines show promise

Editor's pick
Scientific American
28 July 2010
New & experimental HIV treatments

Avexa licenses integrase inhibitor to Chinese partner

Editor's pick
Avexa
14 July 2010
New & experimental HIV treatments

LSUHSC awarded $4 million to understand effect of THC on HIV

Editor's pick
Moreover.com HIV/AIDS feed
7 July 2010